There are 7 goals associated with managing AECOPD -
Prevention progression - Reduce the frequency of
exacerbation phases - Relieve breathlessness and
respiratory symptoms - Improve exersise and daily
activities - Treat exacerbation - Improve quality of life and
health status - Reduce risk of mortality (Lewis,
Heitkemper, Dirksen, Bucher, & Camera, 2014)
someone with COPD mid 80s- low 90%. Oxygen can be dangerous and lead to further complications
-Increased risk of hypoxemia due to lack of ability to effectively exchange CO2 for O2.
Signs of Hypoxemia : Skin colour changes,
Shortness of breath, confusion, wheezing,
rapid heart rate, and rapid breathing.
Smoking Cessation is a large focus for those with COPD
and also those that are excperincing exacerbation. 80-90%
of those with COPD were at one time a smoker. Smoking
leads to an accelerated rate of pulmonary function
decline. Thus causing a increased risk of exacerbation
and risk of severe complications. (Lewis, Heitkemper,
Dirksen, Bucher, & Camera, 2014)
During exacerbation an individuals body can become decompensated due to the extreme
conditions; improving this by ensuring adequate nutrition, exercise and deep breathing and
coughing.
In severe case of AECOPD surgical therapy many be indicated; -Lung volume reducation surgery;
reduces the size of the hyper nflated emphysematous lungs by 20-25% - Lung transpalant if
advanced.
Drug Therapy A crucial part of managing AECOPD. The use of oral and parenteral corticosteroid use
is a rapid methode that reduces the risk of relapse. (Carr, 2008) -A corticosteroid in AECOPD
improves airflow and will recuce the likeliness of alternative treatment failures (Woods, Wheeler,
Finch, & Pinner, 2014) - During a exacerbation period it often leads to a increased amount of drugs
being used, and new ones being introduced this is to help quickly manage the symptoms and seek
a new regimen.
Ensure that client has recieved all vaccinations and their annual influenza and pneumoccacal
vaccine
Avoid exposures to large crowds in peak of influenza season
Oxygen is a drug that should be used with
caution
Thearaputic Nursing Care
Health Promotion
Never smoke or stop smoking all together
Avoid exposure to work and evenviromental pollutants and irratants
Hand hygiene
Vaccinations
Regular check ups with doctor
Early identification and treatment of respiratory tract infections
End of LIfe: identifying
concerns, support decison
making and planning
EXERCISE
Energy Conserving Strategies
Sexual Activity
Sleep
Psychosocial Considertions
Pathophysiology
Bronchitis (Blue
Bloater)
1. Chronic Inflammation and swelling of bronchial mucosa
results in scaring and increased fibrosis of the mucous
membranes and hyperplasia of mucous glands and goblet
cells.
2. Leads to thickenening of the bronchial
walls
3. Obstruction of
airflow
4. Increased levels of eosinophils at site of
inflammation
5. Hypertropy of goblet cells leads to
increased production of mucous
6. Mucus production combined with
purulent exudate forms a bronchial
plug
Often bacterial conolization contains bacteria of the H. influenza and S. pneumoniae
groups
7. Narrowed airway and mucous plugs lead to
improper oxygenation, thus causing high airway
resistance
8. Increased oxygen demand
(Perfusion and ventialation
mismatch)
9. Can lead to oxygen desaturation (cyanosis) due to the inabiltity
to the alveoli exchanging CO2 for O2 slowly. This can lead to an
abundance of alternative issues.
Can also lead to right sided heart failure and edema
(Schumann, 2013, p. 482)
Emphysema (Pink
Puffer)
1. Reductions to the capillary bed occur due to
smoking, enviromental pollutants and certain
occupations.
2. Destroyed alveolar walls cause inflammation
3. Inflammation releases protolytic enzymes such as
macrophages and neutrophils
4. This loss of capillary bed causes reduced
pulmonary abilities and causes the loss of
elasticity
5. Loss of elasticity leads to less exchange of gas and
a increasing pressure around the airway lumen
6. Leads to airway resistance and decreased airflow
7. Air becomes trapped in distal alveoli and
they become distended which can collapse
with the pressure from airway obstruction
(Schumann, 2013, p. 487)
Clinical Manifestations of COPD: Intermittent or productive Cough, sputum production, dyspnea
Diagnostic
Acute Exacerbation of COPD is worsening of clinical manifestations including cough, dyspnea, sputum production
Infectious Triggers
Most common cause of AECOPD
H. influenza & S.pneumoniae
Non-infectious Triggers
Exposure to allergens, irrantants, cold air and air polutions